The Estée Lauder Companies Inc. (NYSE: EL) reported its second quarter 2025 earnings results today.
Net sales decreased 6% year-over-year to $4 billion. Organic sales were also down 6%.
Net loss attributable to the Estée Lauder Companies Inc. was $590 million, or $1.64 per share, compared to net income of $313 million, or $0.87 per share, last year. Adjusted EPS decreased 29% to $0.62.
For the third quarter of 2025, the company expects reported sales to decline 10-12% and organic sales to decline 8-10% YoY. GAAP EPS is projected to be $0.04-0.17 while adjusted EPS is expected to be $0.20-0.30.
Prior performance
The post Key highlights from Estée Lauder’s (EL) Q2 2025 earnings results first appeared on AlphaStreet.
The Estée Lauder Companies Inc. (NYSE: EL) reported its second quarter 2025 earnings results today. Net sales decreased 6% year-over-year to $4 billion. Organic sales were also down 6%. Net
The post Key highlights from Estée Lauder’s (EL) Q2 2025 earnings results first appeared on AlphaStreet.
Categories AlphaGraphs, Consumer, Earnings
Key highlights from Estée Lauder’s (EL) Q2 2025 earnings results
The Estée Lauder Companies Inc. (NYSE: EL) reported its second quarter 2025 earnings results today.
Net sales decreased 6% year-over-year to $4 billion. Organic sales were also down 6%.
Net loss attributable to the Estée Lauder Companies Inc. was $590 million, or $1.64 per share, compared to net income of $313 million, or $0.87 per share, last year. Adjusted EPS decreased 29% to $0.62.
For the third quarter of 2025, the company expects reported sales to decline 10-12% and organic sales to decline 8-10% YoY. GAAP EPS is projected to be $0.04-0.17 while adjusted EPS is expected to be $0.20-0.30.
Prior performance
Listen to the conference calls as they happen. Don’t miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
MRK Earnings: Merck Q4 2024 adj. profit jumps on strong sales growth
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the fourth quarter of 2024, aided by a 7% increase in sales. Fourth-quarter worldwide
PayPal Holdings (PYPL) Q4 2024 Earnings: Key financials and quarterly highlights
PayPal Holdings, Inc. (NASDAQ: PYPL) reported its fourth quarter 2024 earnings results today. Net revenues increased 4% year-over-year to $8.4 billion. Revenue growth was 4% on a currency-neutral basis. GAAP
PFE Earnings: Key quarterly highlights from Pfizer’s Q4 2024 financial results
Pfizer Inc. (NYSE: PFE) reported its fourth quarter 2024 earnings results today. Revenues increased 22% year-over-year to $17.8 billion. GAAP net income was $410 million, or $0.07 per share, compared
Tags
Discover more from World Byte News
Subscribe to get the latest posts sent to your email.
